C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/1998
11/01/1998	CA2236128A1 Novel compounds
10/1998
10/30/1998	CA2236248A1 Crfg-1a, a target and marker for chronic renal failure
10/30/1998	CA2231748A1 Novel g-protein coupled receptor (hfgan72x)
10/30/1998	CA2231741A1 Novel g-protein coupled receptor (hfgan72y)
10/30/1998	CA2228742A1 Crfg-1, a target and marker for chronic renal failure
10/30/1998	CA2228736A1 Crfg-1b, a target and marker for chronic renal failure
10/29/1998	WO1998048283A1 Recombinant rabbit tissue factor based prothrombin time reagent
10/29/1998	WO1998048281A1 Method for the identification and characterization of nuclear receptor ligands
10/29/1998	WO1998048274A1 Homogeneous fluorescence assay for measuring the effect of compounds on gene expression
10/29/1998	WO1998048055A1 Methods and compositions for use in modulating expression of matrix metalloproteinase genes
10/29/1998	WO1998048054A1 Reagents and methods useful for detecting diseases of the prostate
10/29/1998	WO1998048053A1 Reverse transcription method
10/29/1998	WO1998048052A2 Amplification based mutation detection
10/29/1998	WO1998048051A2 Novel molecules of the fthma-070-related protein family and the t85-related protein family and uses thereof
10/29/1998	WO1998048050A1 Method for chromosomes classification
10/29/1998	WO1998048047A2 Characterising dna
10/29/1998	WO1998048046A2 Taqmantm-pcr for the detection of pathogenic e. coli strains
10/29/1998	WO1998048045A2 Method for non-invasive identification of malignant lung tumors
10/29/1998	WO1998048041A2 Dna probes, method and kit for identifying antibiotic-resistant strains of bacteria
10/29/1998	WO1998048035A1 Process for the fermentative production of deacylated cephalosporins
10/29/1998	WO1998048034A1 Process for the fermentative production of deacylated cephalosporins
10/29/1998	WO1998048027A2 Materials and methods for treatment of retinal diseases
10/29/1998	WO1998048026A1 Attenuated salmonella strain used as a vehicle for oral immunization
10/29/1998	WO1998048025A2 Regulatory system for inducible expression of genes with lambdoid promoters
10/29/1998	WO1998048024A1 Type ii tgf-beta receptor/immunoglobulin constant region fusion proteins
10/29/1998	WO1998048023A1 Selection marker
10/29/1998	WO1998048022A1 HUMAN COMPLEMENT C3-DEGRADING PROTEINASE FROM $i(STREPTOCOCCUS PNEUMONIAE)
10/29/1998	WO1998048021A1 Kaposi's sarcoma herpesvirus (hhv8) protease and assembly protein
10/29/1998	WO1998048020A2 Mammalian ubiquitin-isopeptidases that control cell proliferation
10/29/1998	WO1998048019A1 Process for the inactivation of genes which code for enzymes for the catabolism of phenyl acetate, plasmids involved in such process and strains transformed therewith
10/29/1998	WO1998048018A1 Recombinant human beta interferon with enhanced solubility
10/29/1998	WO1998048017A1 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (lir)
10/29/1998	WO1998048016A1 Edg-1-like receptor
10/29/1998	WO1998048015A1 Transcriptional regulator
10/29/1998	WO1998048014A1 Cancer marker
10/29/1998	WO1998048013A1 Brca2 transcriptional activator domain and uses thereof
10/29/1998	WO1998048012A1 Fibroblasts with a foreign gene-containing composition for treating wounds
10/29/1998	WO1998048011A1 Novel chimeric molecules
10/29/1998	WO1998048010A1 Novel human tumour suppressor gene
10/29/1998	WO1998048009A2 Materials and methods for ribozyme treatment of retinal diseases
10/29/1998	WO1998048008A1 Methods for identifying nucleic acid molecules encoding (poly)peptides that interact with target molecules
10/29/1998	WO1998048007A1 Phytochrome regulated transcription factor for control of higher plant development
10/29/1998	WO1998048006A1 Dna sequence coding for a mammalian glucuronyl c5-epimerase and a process for its production
10/29/1998	WO1998048005A1 Targeted gene modification by parvoviral vectors
10/29/1998	WO1998048004A1 Method and compositions for stabilizing unstable gene transcripts
10/29/1998	WO1998048003A1 Calreticulin-deficient cells
10/29/1998	WO1998047921A1 Mammalian cytokines; related reagents and methods
10/29/1998	WO1998047919A1 Materials and methods relating to stabilising substances in cells
10/29/1998	WO1998047918A1 Dirofilaria and brugia ankyrin proteins, nucleic acid molecules, and uses thereof
10/29/1998	WO1998047917A2 A PURIFIED 20 kDa PRESENILIN 2 C-TERMINAL FRAGMENT AND METHODS OF SCREENING FOR COMPOUNDS THAT INHIBIT PROTEOLYSIS OF PRESENILIN 2
10/29/1998	WO1998047916A1 Bifunctional polypeptides for cell-specific viral targeting
10/29/1998	WO1998047912A1 Methods for the production of aslv reverse transcriptases composed of multiple subunits
10/29/1998	WO1998047911A1 Rnase l activators and antisense oligonucleotides effective to treat telomerase-expressing malignancies
10/29/1998	WO1998047541A1 Contrast agents
10/29/1998	WO1998047527A1 Compositions and methods comprising glycogenin-2
10/29/1998	WO1998047391A1 Composition comprising pectin methyl esterase and two substrates
10/29/1998	WO1998047343A2 Antibodies or binding protein libraries displayed on phage, cells, or other replicatable genetic packages
10/29/1998	WO1998041629A3 Death domain containing receptor 5
10/29/1998	WO1998041538A3 Novel human cytokine/steroid receptor protein
10/29/1998	WO1998039426A3 Coxsackie virus vectors for delivery of nucleic acids encoding antigenic or therapeutic products
10/29/1998	WO1998037238A3 Gene sequencer and methods
10/29/1998	WO1998035045A3 Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
10/29/1998	WO1998034601A3 Method for inhibiting intracellular viral replication
10/29/1998	WO1998034121A3 Isolated p27 protein and methods for its production and use
10/29/1998	WO1998030696A3 Secreted proteins and polynucleotides encoding them
10/29/1998	WO1998028971A3 Transgenic animals for in vivo visualization of beta-amyloid toxicity
10/29/1998	WO1998028332A3 Unique dendritic cell-associated c-type lectins, dectin-1 and dectin-2; compositions and uses thereof
10/29/1998	WO1998023762A3 Methods of producing a recombinant protein
10/29/1998	WO1998022589A3 Survivin, a protein that inhibits cellular apoptosis, and its modulation
10/29/1998	DE19717864A1 Humanes rekombinantes Interferon-beta mit verbesserter Löslichkeit Human recombinant interferon-beta with improved solubility
10/29/1998	DE19717656A1 DNA-Sequenzen kodierend für die Untereinheit CHLD pflanzlicher Magnesium-Chelatasen, sowie Verfahren zur Aktivitätsbestimmung pflanzlicher Magnesium-Chelatasen DNA sequences encoding the subunit CHLD vegetable magnesium chelatases, as well as procedures for determining activity of vegetable magnesium chelatases
10/29/1998	DE19717346A1 DNA-Sonden, Verfahren und Kit zur Identifizierung Antibiotika-resistenter Bakterienstämme DNA probes, method and kit for identifying antibiotic-resistant bacterial strains
10/29/1998	CA2797661A1 Targeted gene modification by parvoviral vectors
10/29/1998	CA2288976A1 Phytochrome regulated transcription factor for control of higher plant development
10/29/1998	CA2288335A1 Brca2 transcriptional activator domain and uses thereof
10/29/1998	CA2288272A1 Methods and compositions for use in modulating expression of matrix metalloproteinase genes
10/29/1998	CA2288227A1 A purified 20 kda presenilin 2 c-terminal fragment and methods of screening for compounds that inhibit proteolysis of presenilin 2
10/29/1998	CA2288077A1 Selection marker
10/29/1998	CA2288058A1 Recombinant rabbit tissue factor based prothrombin time reagent
10/29/1998	CA2287590A1 Novel molecules of the fthma-070-related protein family and the t85-related protein family and uses thereof
10/29/1998	CA2287571A1 Reagents and methods useful for detecting diseases of the prostate
10/29/1998	CA2287542A1 Methods for the production of aslv reverse transcriptases composed of multiple subunits
10/29/1998	CA2287508A1 Materials and methods for ribozyme treatment of retinal diseases
10/29/1998	CA2287506A1 Amplification based mutation detection
10/29/1998	CA2287496A1 Characterising dna
10/29/1998	CA2287495A1 Materials and methods for treatment of retinal diseases
10/29/1998	CA2287438A1 Novel human tumour suppressor gene
10/29/1998	CA2287427A1 Homogeneous fluorescence assay for measuring the effect of compounds on gene expression
10/29/1998	CA2287314A1 Rnase l activators and antisense oligonucleotides effective to treat telomerase-expressing malignancies
10/29/1998	CA2287254A1 Mammalian cytokines; related reagents and methods
10/29/1998	CA2287198A1 Calreticulin-deficient cells
10/29/1998	CA2286933A1 Type ii tgf-beta receptor/immunoglobulin constant region fusion proteins
10/29/1998	CA2286865A1 Edg-1-like receptor
10/29/1998	CA2286858A1 Dna sequence coding for a mammalian glucuronyl c5-epimerase and a process for its production
10/29/1998	CA2286761A1 Method for the identification and characterization of nuclear receptor ligands
10/29/1998	CA2286548A1 Fibroblasts with a foreign gene-containing composition for treating wounds
10/29/1998	CA2286479A1 Composition comprising pectin methyl esterase and two substrates
10/29/1998	CA2286310A1 Taqmantm-pcr for the detection of pathogenic e. coli strains
10/29/1998	CA2286210A1 Attenuated salmonella strain used as a vehicle for oral immunization
10/29/1998	CA2283755A1 Human complement c3-degrading proteinase from streptococcus pneumoniae

1 ... 3475 3476 3477 3478 3479 3480 3481 3482 3483 3484 3485 3486 3487 3488 3489 3490 3491 3492 3493 3494 3495 ... 4023